Bjørn Sperling

Safety and efficacy of eptinezumab for migraine prevention in patients with two-to-four previous preventive treatment failures (DELIVER): a multi-arm, randomised, double-blind, placebo-controlled, phase 3b trial

Messoud Ashina, Michel Lantéri‐Minet, Patricia Pozo‐Rosich et al. · The Lancet Neurology · 2022 · 160 citations

Pharmacy, Neurology, Pharmacotherapy +11

Incomplete Brain Infarction of Reperfused Cortex May Be Quantitated With Iomazenil

Jyoji Nakagawara, Bjørn Sperling, Niels A. Lassen · Stroke · 1997 · 132 citations

Medicine, Neuroscience, Pharmacology +17

Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2

Hans‐Christoph Diener, Michael J. Marmura, Stewart J. Tepper et al. · Headache The Journal of Head and Face Pain · 2020 · 102 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Methylprednisolone in combination with interferon beta-1a for relapsing-remitting multiple sclerosis (MECOMBIN study): a multicentre, double-blind, randomised, placebo-controlled, parallel-group trial

Mads Ravnborg, Per Soelberg Sørensen, Magnus Andersson et al. · The Lancet Neurology · 2010 · 75 citations

Pharmacy, Neurology, Pharmacotherapy +9

Cerebral lactate production and blood flow in acute stroke

Ole Henriksen, Peter Gideon, Bjørn Sperling et al. · Journal of Magnetic Resonance Imaging · 1992 · 51 citations

Medicine, Neurology, Neuroscience +17